Login / Signup

Endovascular therapy versus femoropopliteal bypass surgery for medium-length TASC II B and C lesions of the superficial femoral artery: An observational propensity-matched analysis.

Rianne J VossenA C VahlT M FokkemaV J LeijdekkersAd Montauban van SwijndregtR Balm
Published in: Vascular (2019)
Keyphrases
  • minimally invasive
  • coronary artery bypass
  • stem cells
  • cross sectional
  • coronary artery disease
  • mesenchymal stem cells
  • atrial fibrillation
  • bone marrow
  • percutaneous coronary intervention
  • cell therapy